General Information of Drug Transporter (DT)
DT ID DTD0377 Transporter Info
Gene Name SLC49A2
Transporter Name Feline leukemia virus subgroup C receptor-related protein 2
Gene ID
55640
UniProt ID
Q9UPI3
Post-Translational Modification of This DT
Overview of SLC49A2 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X-Ubiquitination X: Amino Acid

Phosphorylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC49A2 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

512

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A2 Serine 512 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC49A2 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

515

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A2 Serine 515 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC49A2 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

522

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A2 Serine 522 has the potential to affect its expression or activity.

  Threonine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC49A2 [1] , [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

514

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC49A2 Threonine 514 has the potential to affect its expression or activity.

Ubiquitination

  Glycine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC49A2 [4]

Role of PTM

Potential impacts

Modified Residue

Glycine

Modified Location

299

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC49A2 Glycine 299 has the potential to affect its expression or activity.

  Lysine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC49A2 [4]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

504

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC49A2 Lysine 504 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC49A2 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

516

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC49A2 Lysine 516 has the potential to affect its expression or activity.

  Valine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC49A2 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Valine

Modified Location

311

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC49A2 Valine 311 has the potential to affect its expression or activity.
References
1 Comparative phosphoproteomic analysis reveals signaling networks regulating monopolar and bipolar cytokinesis. Sci Rep. 2018 Feb 2;8(1):2269.
2 Integrated Proteomics Reveals Apoptosis-related Mechanisms Associated with Placental Malaria. Mol Cell Proteomics. 2019 Feb;18(2):182-199.
3 Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61.
4 Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021 Jun;594(7862):246-252.
5 UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
6 Integrative Analysis of Proteome and Ubiquitylome Reveals Unique Features of Lysosomal and Endocytic Pathways in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells. Proteomics. 2018 Aug;18(15):e1700388.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.